Bio-Rad Laboratories | BIO - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 299M 231M 2026-06
Agilent USD 25M 0 2026-03
Becton, Dickinson and Co. USD 149M 4M 2026-03
Bio Techne USD 2.17M 9K 2025-12
Bio-Rad Laboratories USD 12.1M 200K 2025-12
Bruker USD 8.1M 11.9M 2025-12
Charles River Laboratories USD 26.74M 2.97M 2026-03
Danaher USD 63M 8M 2026-03
General Electric Aerospace USD 496M 271M 2025-12
Illumina USD 26M 1000K 2025-12
IQVIA Holdings USD 192M 1000K 2026-03
Laboratory Of America USD 55.1M 100K 2026-03
Merck USD 479M 67M 2026-03
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Repligen USD 5.58M 83K 2026-03
Revvity USD 24.72M 1.2M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Siemens EUR 435M 1000K 2025-12
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Tosoh JPY 884M 65M 2025-09
Waters USD 42M 33.38M 2026-03